Memory Training for Breast Cancer Survivors
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a memory training program for breast cancer survivors who have experienced memory problems after chemotherapy. The study assesses whether these individuals can improve memory and attention using one of two software versions: the Cogmed Working Memory Training Program or a less challenging comparison version. Participants will be randomly assigned to one of these versions. Women who have survived Stage I-III breast cancer, completed chemotherapy in the past 1-10 years, and have noticeable memory issues might be a good fit for this trial. As an unphased trial, this study offers participants the opportunity to contribute to research that could enhance cognitive recovery for future breast cancer survivors.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It is best to discuss this with the trial coordinators or your doctor.
What prior data suggests that this memory training program is safe for breast cancer survivors?
Studies have shown that the Cogmed Working Memory Training Program is generally safe. This program has been used in various settings without major safety issues. It is software designed to improve memory and attention.
Research on similar programs has demonstrated effectiveness for individuals with cognitive issues following cancer treatment. These programs have been safely used with both children and adults, including those recovering from cancer and stroke.
The Cogmed program has not been linked to harmful side effects. Users typically do not experience negative effects, suggesting it is well-tolerated, even as it is specifically tested for breast cancer survivors in this study.12345Why are researchers excited about this trial?
Researchers are excited about the Cogmed Working Memory Training Program because it offers a non-drug approach to address cognitive difficulties experienced by breast cancer survivors. Unlike traditional treatments that may involve medication to manage symptoms, this program focuses on enhancing cognitive function through targeted exercises designed to improve working memory. This method provides a promising alternative for those looking to avoid medication-related side effects, offering potential improvements in memory and cognition without pharmaceutical intervention.
What evidence suggests that this memory training program could be effective for breast cancer survivors?
Studies have shown that the Cogmed Working Memory Training Program can improve memory in cancer patients, including those recovering from chemotherapy. For example, a 5-week program helped young cancer survivors enhance their memory. Research also shows that similar training has led to better memory and verbal learning in cancer patients. Although it hasn't been tested specifically on breast cancer survivors, these findings suggest it might help with memory issues after chemotherapy. This trial will evaluate the effectiveness of the Cogmed Working Memory Training Program specifically for breast cancer survivors. Early results from other studies indicate that cognitive training can effectively improve memory in breast cancer patients.12678
Who Is on the Research Team?
Elizabeth Ryan, PhD
Principal Investigator
Memorial Sloan Kettering Cancer Center
Are You a Good Fit for This Trial?
This trial is for female breast cancer survivors aged 18-69 who've had chemotherapy 1-10 years ago and are currently disease-free. They must speak English, have basic computer skills, internet access, and show memory problems on specific tests. Excluded are those with significant past brain injury or cognitive issues from other conditions.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo a 5-week memory training program using one of two software versions to improve memory and attention problems
Follow-up
Participants complete two follow-up neurocognitive assessments to test for maintenance of treatment effect
What Are the Treatments Tested in This Trial?
Interventions
- Cogmed Working Memory Training Program
Find a Clinic Near You
Who Is Running the Clinical Trial?
Memorial Sloan Kettering Cancer Center
Lead Sponsor
MARTELL FOUNDATION
Collaborator